Michael Choi is a seasoned Senior Medical Director and Scientist-Entrepreneur specializing in gastroenterology. They served as an Assistant Professor of Medicine at Harvard Medical School from 2009 to 2021, where they led a lab focused on novel liver fibrosis therapies. Currently, Michael holds the positions of Scientific Advisor at Iterative Health and Co-Founder at Mediar Therapeutics, while also serving as Senior Director of Clinical Development at Eli Lilly and Company, supporting Phase 3 IBD studies. Their past roles include Director of Clinical Development at Morphic Therapeutic, where they designed critical ulcerative colitis clinical trials, and Research Fellow at Dana-Farber Cancer Institute, where they trained in developmental biology. Michael's education includes a Bachelor of Arts in Biology from Cornell University and an M.D. from the same institution, alongside ongoing training in internal medicine and gastroenterology.
This person is not in any teams
This person is not in any offices